| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/31/1997 | CA2245002A1 Malaria vaccine based upon the addition of a msa1 peptide |
| 07/31/1997 | CA2244881A1 Amplification of response from expressed recombinant protein |
| 07/31/1997 | CA2244693A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | CA2244412A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2244147A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | CA2243529A1 Retroviral vector and its use in gene therapy |
| 07/31/1997 | CA2242960A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | CA2242200A1 Toxoplasma gondii antigen tg20 |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/30/1997 | EP0786521A1 Nucleic acid encoding PspA |
| 07/30/1997 | EP0786005A1 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy |
| 07/30/1997 | EP0786004A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 07/30/1997 | EP0785987A2 Flow through electroporation apparatus and method |
| 07/30/1997 | EP0785803A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 07/29/1997 | US5652356 Inverted chimeric and hybrid oligonucleotides |
| 07/29/1997 | US5652355 Hybrid oligonucleotide phosphorothioates |
| 07/29/1997 | US5652224 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 07/29/1997 | US5652223 DNA encoding CAI resistance proteins and uses thereof |
| 07/29/1997 | US5652222 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides |
| 07/29/1997 | US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM |
| 07/29/1997 | US5652130 Retroviral vectors expressing tumor necrosis factor (TNF) |
| 07/29/1997 | US5652118 Nucleic acid encoding a novel morphogenic protein, OP-3 |
| 07/29/1997 | US5652113 Contacting nonneuronal cells expressing on their cell surface the human serotonin receptor with chemical compound under conditions suitable for binding, detecting specific binding of compound to receptor |
| 07/29/1997 | US5652095 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/29/1997 | US5652094 Nucleozymes |
| 07/29/1997 | US5651980 Methods of use of uncoated gel particles |
| 07/29/1997 | US5651964 Transfection, gene expression, antitumor, anticarcinogenic |
| 07/29/1997 | CA1339096C Novel one step method and polynucleotide compounds for hybridizing to target polynucleotides |
| 07/24/1997 | WO1997026535A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026360A1 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells |
| 07/24/1997 | WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026353A1 ALANYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026352A1 STAPHYLOCOCCUS AUREUS SERYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026350A1 STAPHYLOCOCCUS AUREUS METHIONYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026348A1 ASPARAGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026341A1 CYSTEINYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026340A1 STAPHYLOCOCCUS AUREUS GLYCYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026338A1 Staphylococcus aureus wcuh29 spoiiie protein |
| 07/24/1997 | WO1997026337A1 Methods for delivering dna to muscle cells using recombinant adeno-associated virus virions |
| 07/24/1997 | WO1997026336A1 Compositions for treating anemia |
| 07/24/1997 | WO1997026334A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026327A1 Compositions and methods for mediating cell cycle progression |
| 07/24/1997 | WO1997026325A1 Compositions and their uses for transfer of down-regulatory genes into cells associated with inflammatory responses |
| 07/24/1997 | WO1997026321A2 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | WO1997026274A1 Leptospiral outer membrane proteins |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997025860A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | WO1997018300A3 Murine model for human carcinoma |
| 07/24/1997 | WO1997015668A3 Methods and compositions comprising glut-2 and glut-2 chimeras |
| 07/24/1997 | WO1997014808A3 Herpesvirus vectors and their uses |
| 07/24/1997 | CA2844461A1 Compositions for treating anemia |
| 07/24/1997 | CA2246431A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | CA2246268A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | CA2243470A1 Recombinant aav virion for expressing epo in a mammal |
| 07/24/1997 | CA2242376A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | CA2241952A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | CA2215900A1 Leptospiral outer membrane proteins |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785270A1 Staphylococcus aureus Seryl-tRNA synthetase |
| 07/23/1997 | EP0785269A1 Histidyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785268A1 Staphylococcus aureus methionyl-tRNA synthetase |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785260A1 Alanyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785259A1 Asparaginyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0785257A1 Cysteinyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785256A1 Staphylococcus aureus glycyl-tRNA synthetase |
| 07/23/1997 | EP0785254A2 Phosphatidyl-ionsitol glycan class F (PIG-F), the cDNA encoding it and their use as medicament |
| 07/23/1997 | EP0785252A1 Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer |
| 07/23/1997 | EP0785216A1 Chomosome 13-linked breast cancer susceptibility gene BRCA2 |
| 07/23/1997 | EP0784693A1 Viral vectors and line for gene therapy |
| 07/23/1997 | EP0784691A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 07/23/1997 | EP0784690A1 Complementary adenoviral vector systems and cell lines |
| 07/23/1997 | EP0784683A1 Tie-2 ligands, methods of making and uses thereof |
| 07/23/1997 | EP0784681A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 07/23/1997 | EP0784680A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 07/23/1997 | EP0784679A1 Cancer treatment by expression of differentiation factor receptor |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0784672A1 Human inositol monophosphatase h1 |